Search results
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 hours agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
What to know about upcoming COVID-19 vaccines and the FLiRT variants
GBH News· 7 days agoThe federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Los Angeles· 4 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Moderna says combo COVID-flu vaccine showing promising results — and more
WGN Chicago via Yahoo News· 3 days agovaccine is showing promising results. Biotech company Moderna says the combination shot was shown to...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
CNN.com· 6 days agoThe US Food and Drug Administration announced Friday that it had advised the makers of the Covid-19 ...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation...
KION 46 Salinas· 6 days agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
AOL· 3 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna, which is developing the experimental vaccine ...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
WUSF 89.7· 6 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
Moderna's two-in-one flu and Covid vaccine passes advanced trial
BBC News· 4 days agoDrug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 1 day agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin ...